Is Eltrombopag a self-paid drug or is it covered by medical insurance?
Eltrombopag (Eltrombopag) has been launched in China and has been included in medical insurance coverage. This means that when patients are treated with eltrombopag, they can reimburse part of the cost through medical insurance, reducing the burden of medication. Eltrombopag is mainly used to treat diseases such as chronic immune thrombocytopenia (ITP). As a drug that promotes platelet production, it has a significant effect on increasing patients' platelet levels.
In terms of price, the domestic price of eltrombopag ranges from more than 1,000 yuan to 4,000 to 5,000 yuan. The specific price is affected by the dosage and packaging specifications. When purchasing, patients should choose the appropriate dosage and packaging according to the doctor's prescription, and consult the local hospital pharmacy's medical insurance reimbursement policy. The coverage of medical insurance allows more patients to afford eltrombopag and receive timely and effective treatment.
In overseas markets, the original drug of eltrombopag is mainly produced by Novartis of India, with two specifications: 25mg14 tablets and 50mg14 tablets. The price of the 25mg specification is about 1,700 yuan, and the 50mg specification is less than 3,000 yuan. In contrast, generic versions of eltrombopag are also sold in Laos, India, Bangladesh and other places. The drug ingredients are basically the same as the original drug, but the price is more affordable, usually only a few hundred yuan. This provides patients with more affordable options.
Generally speaking, Eltrombopag is supported by medical insurance and comes in a variety of prices and specifications. Domestic patients should give priority to purchasing through formal channels covered by medical insurance to ensure drug quality and efficacy. At the same time, for patients with limited financial conditions, overseas generic drugs can also be a reasonable supplementary choice, but it is necessary to ensure that the sources of drugs are regular and avoid using fake and shoddy products.
Reference materials:https://go.drugbank.com/drugs/DB06210
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)